BioSpace News Archive

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2020, and provided a corporate update.

New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots

Veteran Industry Executive Brings Broad and Varied Experience Across Biotech Sectors

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will present at the Bank of America 2020 Health Care Conference on Thursday, May 14, 2020 at 3:00 p.m. ET.

BrainsWay Ltd. announced that Hadar Levy has been promoted to Senior Vice President and General Manager of North America, and Judith Huber has been appointed the Company’s Senior Vice President and Chief Financial Officer, effective May 11, 2020.

Announcing CCR8 as JTX-1811 target; new preclinical data to be presented at the AACR 2020 June virtual meeting

CENTOGENE, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced the expansion of its Senior Leadership Team with the appointment of Angelos Baxevanis as Senior Vice President Communication and Marketing.

ChromaDex highlights additional clinical and preclinical research strengthening science and understanding behind Niagen®

CVS Health Corporation announced operating results for the three months ended March 31, 2020.

Ra Medical Systems, Inc. announces that it will report first quarter 2020 financial results and provide a business update after market close on Wednesday, May 13, 2020.